TNF and irritable bowel syndrome: Most recently, Ventin-Holmberg et al. assessed fecal samples of 30 pediatric IBD patients to determine ITS-based mycobiota profiles before and during anti-tumor necrosis factor alpha (TNFα) treatment, a key biological treatment in IBD [55].